Biopharma company that creates subsidiary Vants focused on specific therapeutic areas. Provides clinical development capabilities through its platform including data analytics (Datavant) and trial technology.
Vendor description
Biopharma platform with clinical development technology
Clinical development platforms,Therapeutic-area-focused drug development,Data analytics (Datavant)
- Innovative Vant model
- Datavant data platform
- Therapeutic depth
- Nasdaq-listed (ROIV)
- Drug developer first,vendor second
- Not a traditional CRO model
Approved customer reviews
Write a reviewNo reviews yet
Be the first customer to share verified experience with this vendor.
Pricing
$
Key facts
| HQ country | United States |
|---|---|
| Geography | Global |
| Service model | Full-service + FSP |
| Study phases | Phase I, Phase II, Phase III, Phase IV |
| Trial scale | Medium,Large,Global |
| Therapeutic areas | Oncology, Immunology, Neurology, Rare diseases, Inflammatory disease |
Related vendors
Editorial ranking
See how Roivant Sciences compares - best Specialist CRO vendors for clinical trials.